The great imitator revealed: syphilis.
This article is based on a presentation by Jeffrey D. Klausner, MD, MPH, at the 2018 Clinical Conference at the National Ryan White Conference on HIV Care and Treatment in December 2018. PMID: 31136995 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - May 30, 2019 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

The intersection of intimate partner violence and HIV: detection, disclosure, discussion, and implications for treatment adherence.
This article is based on a presentation by Tami P. Sullivan, PhD, at the 2018 Clinical Conference at the National Ryan White Conference on HIV Care and Treatment in December 2018. PMID: 31136996 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - May 30, 2019 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Fatty liver disease in persons with HIV infection.
Authors: Seth A, Sherman KE Abstract The leading cause of non-HIV-related mortality is liver disease. Fatty liver disease can be characterized as alcoholic or nonalcoholic in nature. Alcohol use is prevalent among individuals with HIV infection and can lead to medication nonadherence, lower CD4+ cell count, inadequate viral suppression, and disease progression. The pathogenesis of nonalcoholic fatty liver disease (NAFLD) in individuals with HIV infection includes metabolic syndrome, hyperuricemia, HIV-related lipodystrophy, genetic polymorphisms, medications, HIV itself, and the gut microbiome. The prevalence of NA...
Source: Topics in antiviral medicine - May 30, 2019 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

CROI 2019: advances in basic science understanding of HIV.
Authors: Stevenson M Abstract The annual Conference on Retroviruses and Opportunistic Infections remains the preeminent venue for the sharing and dissemination of research advances in the field of HIV and AIDS research. The 26th conference in Seattle featured highlights including news of additional individuals who experienced long-term virologic remission following a bone marrow transplant. The factors driving reservoir persistence gathered a lot of interest, as well as data presented on new factors involved in regulating HIV-1 latency. The effectiveness of the conference in disseminating new findings is further en...
Source: Topics in antiviral medicine - May 30, 2019 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

CROI 2019: advances in HIV prevention and plans to end the epidemic.
Authors: Buchbinder SP, Liu AY Abstract At the 2019 Conference on Retroviruses and Opportunistic Infections (CROI), a plan for ending the HIV epidemic in the United States was presented. More rapid HIV diagnosis and treatment is a key component needed nationwide. In international settings, substantial scale up of HIV testing and treatment has led to substantial declines in HIV incidence. U=U (undetectable equals untransmittable) is a powerful concept that can reduce stigma and encourage engagement in testing and care, but raises a number of clinical questions. HIV testing remains a gateway to HIV prevention and tre...
Source: Topics in antiviral medicine - May 30, 2019 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

CROI 2019: neurologic complications of HIV disease.
Authors: Ances BM, Letendre SL Abstract Investigators reported many new neuroHIV research findings at the 2019 Conference on Retroviruses and Opportunistic Infections (CROI). These findings included confirmation that HIV-associated neurocognitive disorder (HAND) remains common with an increasingly recognized role for comorbidities (eg, obesity) and neurodegenerative conditions (eg, Alzheimer's disease), especially as persons living with HIV (PLWH) advance into their seventh decade of life and beyond. HAND is increasingly recognized as a heterogeneous disorder that differs between individuals (eg, by sex) in the tra...
Source: Topics in antiviral medicine - May 30, 2019 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

CROI 2019: complications and coinfections in HIV infection.
Authors: Currier JS, Havlir DV Abstract The 2019 Conference on Retroviruses and Opportunistic Infections provided a considerable amount of new information on the progress in implementation of strategies to reduce morbidity and mortality from complications and coinfections that occur in people with HIV infection, and on the clinical management of these important problems. This review will address new insights into the prevention and treatment of tuberculosis, fungal infections, sexually transmitted infections, malignancies, and a range of metabolic complications and noncommunicable diseases. PMID: 31137001 [PubM...
Source: Topics in antiviral medicine - May 30, 2019 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

CROI 2019: highlights of viral hepatitis.
Authors: Luetkemeyer AF, Wyles DL Abstract At the 2019 Conference on Retroviruses and Opportunistic Infections (CROI), there was a major focus on hepatitis C virus (HCV) elimination and improving each component of the hepatitis C care cascade. Many interventions showed promising improvements in diagnosis and linkage to care. Settings with robust access to direct-acting antivirals (DAAs) continue to demonstrate the role of HCV treatment as prevention. However, substantial barriers to accessing curative therapy remain. Reinfection after treatment presents an important barrier to elimination, particularly in some popu...
Source: Topics in antiviral medicine - May 30, 2019 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

CROI 2019: advances in antiretroviral therapy.
Authors: Taylor BS, Tieu HV, Jones J, Wilkin TJ Abstract The 2019 Conference on Retroviruses and Opportunistic Infections included many exciting advances in antiretroviral therapy (ART). Investigators presented a case report of a second patient possibly cured of HIV through an allogeneic hematopoietic stem cell transplant from a CC chemokine receptor 5-delta 32 donor. Two clinical trials of long-acting injectable cabotegravir and rilpivirine showed promising safety, efficacy, and tolerability as maintenance ART. Test-and-treat and rapid-ART-start strategies show promise in advancing progress toward the HIV care cas...
Source: Topics in antiviral medicine - May 30, 2019 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Treating HCV Infection: It Doesn't Get Much Better Than This.
This article summarizes an IAS-USA webinar given by Susanna Naggie, MD, MHS, on August 30, 2018. PMID: 30641483 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - January 16, 2019 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Forgotten but Not Gone: Learning From the Hepatitis A Outbreak and Public Health Response in San Diego.
This article summarizes an IAS-USA continuing education webinar given by Darcy A. Wooten, MD, on July 19, 2018. PMID: 30641485 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - January 16, 2019 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

The human microbiome: implications for health and disease, including HIV infection.
This article summarizes a presentation by Robert T. Schooley, MD, at the IAS-USA continuing education program held in San Francisco in May 2018. PMID: 30384329 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - November 3, 2018 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Recurring and emerging questions related to management of HIV-related opportunistic infections.
This article summarizes a presentation by Henry Masur, MD, at the IAS-USA continuing education program held in Washington, DC, in April 2018. PMID: 30384330 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - November 3, 2018 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Human papillomavirus-related malignancies in HIV infection: anal and oropharyngeal cancers.
This article summarizes a presentation by Timothy J. Wilkin, MD, MPH, at the IAS-USA continuing education program held in Los Angeles, California in April 2018. PMID: 30384331 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - November 3, 2018 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Opioid addiction, opioid addiction treatment, and HIV infection.
This article summarizes a presentation by R. Douglas Bruce, MD, MA, MS, at the IAS-USA continuing education program held in Chicago, Illinois, in May 2018. PMID: 30384332 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - November 3, 2018 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Policy and advocacy for the HIV practitioner.
Authors: Del Rio C, Armstrong WS Abstract In no field of medicine has advocacy, including physician advocacy, been more crucial in shaping policy for delivery of care than in HIV/AIDS. Although the historic tradition is strong, there is an urgent need to re-energize advocacy efforts nationally and internationally to support programs that fund care, change policies that perpetuate stigma and discrimination, and change the public perception that the HIV/AIDS crisis is over. Established programs that require ongoing advocacy attention include the Ryan White Comprehensive AIDS Resources Emergency Act, a US program that...
Source: Topics in antiviral medicine - November 3, 2018 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

New and Noteworthy in Tuberculosis Diagnostics and Treatment.
This article summarizes a presentation by Susan Swindells, MBBS, at the Ryan White HIV/AIDS Program Clinical Care Conference held in San Antonio in August 2017. PMID: 29906789 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - June 17, 2018 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Strategies for Linkage to and Engagement With Care: Focus on Intervention.
This article summarizes a presentation by Thomas P. Giordano, MD, MPH, at the Ryan White HIV/AIDS Program Clinical Conference held in San Antonio, Texas, in August 2017. PMID: 29906790 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - June 17, 2018 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

CROI 2018: Epidemic Trends and Advances in HIV Prevention.
Authors: Buchbinder SP, Liu AY Abstract At the 2018 Conference on Retroviruses and Opportunistic Infections, trends in and risk factors for in HIV infection were highlighted. In the United States, new HIV diagnoses are highest in the South and among African Americans and are increasing in rural areas. Youth remain highly vulnerable to HIV infection globally. The epidemiology of HIV infections among people who inject drugs is changing, with overdose deaths, a major public health concern. Phylogenetics are being used to identify HIV transmission clusters and hotspots, which can inform prevention efforts. Vaginal micr...
Source: Topics in antiviral medicine - May 8, 2018 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

CROI 2018: Advances in Basic Science Understanding of HIV.
Authors: Stevenson M Abstract The conference on Retroviruses and Opportunistic Infections represents the most important venue for the dissemination of research advances in HIV and AIDS. The 25th conference, held in Boston, featured presentations that provided insight into the mechanisms of HIV-1 spread in tissues as well as new information on mechanisms of HIV-1 persistence in individuals on effective antiretroviral treatment. The ability of the conference to convey research findings for a general audience is enhanced, to a large part, by preconference workshops. These workshops feature leading researchers who aim ...
Source: Topics in antiviral medicine - May 8, 2018 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

CROI 2018: Complications of HIV Infection and Antiretroviral Therapy.
Authors: Currier JS, Havlir DV Abstract This year marked the 25th Conference on Retroviruses and Opportunistic Infections (CROI), and although there is much progress to celebrate in terms of treatment of HIV infection and expanding ART globally, many challenges remain. Tuberculosis is still the leading cause of death among people with HIV infection globally. This year, the results of investments in research to improve the prevention and treatment of tuberculosis were a highlight of the meeting. Noninfectious causes remain an important source of morbidity. Progress in identifying risk factors for non-AIDS complicati...
Source: Topics in antiviral medicine - May 8, 2018 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

CROI 2018: Highlights of Viral Hepatitis.
Authors: Luetkemeyer AF, Wyles DL Abstract At the 2018 Conference on Retroviruses and Opportunistic Infections (CROI), there was a major focus on hepatitis C virus (HCV) elimination and improving each component of the hepatitis C care cascade. Several countries and cohorts have demonstrated the remarkable impact that universal HCV testing and unrestricted access to hepatitis C treatment can have on markedly reducing incident HCV infections and HCV infection prevalence, including in people who inject drugs and HIV/HCV-coinfected populations. However, in many settings, substantial barriers to widespread HCV treatment...
Source: Topics in antiviral medicine - May 8, 2018 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

CROI 2018: Advances in Antiretroviral Therapy.
Authors: Tieu HV, Taylor BS, Jones J, Wilkin TJ Abstract The 2018 Conference on Retroviruses and Opportunistic Infections (CROI) showcased exciting data on new investigational agents including MK-8591 and tri-specific antibody targeting 3 highly conserved epitopes on HIV-1 in a single antibody. Clinical trials of initial antiretroviral therapy (ART) and switch studies involving bictegravir/emtricitabine/tenofovir alafenamide were presented. Intensification of initial ART with integrase strand transfer inhibitors did not increase the risk of immune reconstitution inflammatory syndrome. Pharmacokinetic issues were di...
Source: Topics in antiviral medicine - May 8, 2018 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Abstracts from the 2018 Conference on Retroviruses and Opportunistic Infections. March 4-7, 2018. Boston, Massachusetts.
Authors: PMID: 29689542 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - April 26, 2018 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Neurologic Complications in Persons With HIV Infection in the Era of Antiretroviral Therapy.
This article summarizes a presentation by Dennis Kolson, MD, PhD, at the IAS-USA continuing education program, Improving the Management of HIV Disease, held in Chicago, Illinois, in May 2017. PMID: 28820724 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - August 20, 2017 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Understanding Hepatitis C Virus Drug Resistance: Clinical Implications for Current and Future Regimens.
Authors: Wyles DL, Luetkemeyer AF Abstract Viral resistance to direct-acting antiviral drugs may impact their effectiveness during treatment of hepatitis C virus (HCV) infection. Most data on HCV drug resistance concern genotypes 1 and 3. The clinical impact of resistance to HCV nonstructural protein 5A (NS5A) inhibitors and a practical approach to indications and methods for resistance testing are discussed. PMID: 28820725 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - August 20, 2017 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Barriers to Treatment Access for Chronic Hepatitis C Virus Infection: A Case Series.
Authors: Millman AJ, Ntiri-Reid B, Irvin R, Kaufmann MH, Aronsohn A, Duchin JS, Scott JD, Vellozzi C Abstract Restrictive policies on access to new, curative hepatitis C treatments represent a substantial barrier to treating patients infected with hepatitis C. This case series demonstrates challenges experienced by patients and practitioners in accessing these treatments and highlights several strategies for navigating the treatment preauthorization process. PMID: 28820726 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - August 20, 2017 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Sustained Off-Treatment Response After Discontinuation of Long-Term Nucleos(t)ide Analogue Treatment in HBeAg-Seronegative Hepatitis B: A Case Series.
Authors: Muche M, Meyer U, Siegmund B, Somasundaram R, Epple HJ Abstract International guidelines recommend lifelong nucleos(t)ide analogue (NA) treatment in individuals with chronic hepatitis B (CHB) infection who are hepatitis B e antigen (HBeAg) seronegative, because hepatitis B surface antigen (HBsAg) seroconversion is rarely achieved. However, after terminating therapy, sustained responses and HBsAg loss have been observed. Clinical characteristics identifying persons with favorable outcomes after discontinuing NA therapy have not yet been defined. This case series describes outcomes of 6 individuals with HBeA...
Source: Topics in antiviral medicine - August 20, 2017 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

CROI 2017: Basic Science Review.
Authors: Stevenson M Abstract The Conference on Retroviruses and Opportunistic Infections (CROI) continues to be the preeminent gathering for HIV/AIDS researchers. It provides a forum in which investigators involved in all aspects of research on HIV/AIDS and related conditions can present and be updated on the latest scientific developments in the field. In 2017, basic research continued to be strongly represented at the conference. Most of the presentations focused on mechanisms of viral persistence in the face of effective antiretroviral therapy as well as approaches to measuring viral reservoirs and intervening ...
Source: Topics in antiviral medicine - June 11, 2017 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

CROI 2017: HIV Epidemic Trends and Advances in Prevention.
Authors: Liu AY, Buchbinder SP Abstract At the 2017 Conference on Retroviruses and Opportunistic Infections (CROI), trends in the HIV epidemic were highlighted, with decreasing HIV incidence reported across several countries, although key groups remain underdiagnosed and undertreated. In the United States, men who have sex with men (MSM) continue to comprise the largest number of new and undiagnosed HIV infections, with rising incidence in MSM 25 to 34 years old and Latino MSM. Phylogenetics are being used to identify rapidly growing HIV transmission clusters, which can inform prevention efforts. HIV testing is a c...
Source: Topics in antiviral medicine - June 11, 2017 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

CROI 2017: Advances in Antiretroviral Therapy.
Authors: Jones J, Taylor BS, Tieu HV, Wilkin TJ Abstract The 2017 Conference on Retroviruses and Opportunistic Infections (CROI) featured exciting preclinical data on investigational antiretroviral agents with good in vitro efficacy and long half-lives. Investigational medications, including bictegravir, demonstrated excellent efficacy and tolerability, as did dual-agent therapy with dolutegravir paired with rilpivirine or with lamivudine. Dolutegravir monotherapy proved inadvisable due to virologic failure and resistance. The gap between high- and low-income settings along the HIV care continuum is narrowing, with...
Source: Topics in antiviral medicine - June 11, 2017 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

CROI 2017: Neurologic Complications of HIV Infection.
Authors: Spudich SS, Ances BM Abstract The brain is a major target for HIV infection and is a potential viral reservoir even in virologically well-controlled HIV-infected individuals. Data presented at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) suggested that during early HIV infection, CD4+ T cells in the meninges and choroid plexus serve as an important early site of HIV infection in the central nervous system (CNS), with brain macrophages and microglial cells becoming an important source of viral replication with advancing disease. Longitudinal evaluations of HIV-associated neurocogn...
Source: Topics in antiviral medicine - June 11, 2017 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

CROI 2017: Complications and Comorbidities of HIV Disease and Its Treatment.
Authors: Currier JS, Havlir DV Abstract Complications of HIV disease remained a major focus at the 2017 Conference on Retroviruses and Opportunistic Infections (CROI), and included studies focused on noncommunicable chronic diseases (eg, cardiovascular disease, obesity, bone disease, and malignancies) and opportunistic infections (Mycobacterium tuberculosis and cryptococcosis). Progress in identifying predictors of specific complications as well as interventions for the prevention and treatment of these comorbidities are summarized below. PMID: 28598792 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - June 11, 2017 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

CROI 2017: Highlights of Advances in Viral Hepatitis and Liver Fibrosis.
Authors: Luetkemeyer AF, Wyles DL Abstract At the 2017 Conference on Retroviruses and Opportunistic Infections (CROI) in Seattle, Washington, hepatitis C virus (HCV) infection was a major focus in the context of HIV-associated liver disease. Well-tolerated direct-acting antiviral (DAA) regimens have enabled effective treatment of the populations that are hardest to cure, including those with decompensated cirrhosis, and many studies examined the impact of HCV cure on hepatitis and extrahepatic outcomes. Scaling up access to DAA, and the impact that their universal availability can have on reducing prevalence were k...
Source: Topics in antiviral medicine - June 11, 2017 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Hepatitis C Virus, Inflammation, and Cellular Aging: Turning Back Time.
This article summarizes a presentation by Susanna Naggie, MD, MHS, at the IAS-USA continuing education program, Management of Hepatitis C Virus in the New Era: Small Molecules Bring Big Changes, in New York, New York, in September 2015. PMID: 28402927 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - April 14, 2017 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Management of Advanced Fibrosis in the Context of Hepatitis C Virus Infection.
This article summarizes a presentation by Elizabeth C. Verna, MD, at the IAS-USA continuing education program, Management of Hepatitis C Virus in the New Era: Small Molecules Bring Big Changes, held in New York, New York, in September 2015. PMID: 28402928 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - April 14, 2017 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Kidney Disease and HIV Infection.
This article summarizes a presentation by Christina M. Wyatt, MD, at the Ryan White HIV/AIDS Program Clinical Care Conference held in New Orleans, Louisiana, in December 2015. PMID: 28402929 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - April 14, 2017 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

HIV Treatment and Prevention: An Overview of Recommendations From the IAS-USA Antiretroviral Guidelines Panel.
This article summarizes an IAS-USA continuing education webinar presented by Paul A. Volberding, MD, in August 2016. PMID: 28402930 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - April 14, 2017 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Abstracts from the 2015 Conference on Retroviruses and Opportunistic Infections. February 23-26, 2015. Seattle, Washington.
Authors: PMID: 28394762 [PubMed] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - April 13, 2017 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Abstracts from the 2016 Conference on Retroviruses and Opportunistic Infections. February 22-25, 2016. Boston, Massachusetts.
Authors: PMID: 28394761 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - April 11, 2017 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Abstracts from the 2017 Conference on Retroviruses and Opportunistic Infections. February 13-16, 2017. Seattle, Washington.
Authors: PMID: 28394763 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - April 11, 2017 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

HIV Infection in Hard-to-Reach Populations.
This article summarizes a presentation by Carlos del Rio, MD, at the IAS-USA continuing education program, Improving the Management of HIV Disease, held in New York, New York, in March 2016. PMID: 27841977 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - November 16, 2016 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

HIV Transmission and Injection Drug Use: Lessons From the Indiana Outbreak.
This article summarizes a presentation by Diane M. Janowicz, MD, at the IAS-USA continuing education program, Improving the Management of HIV Disease, held in Los Angeles, California, in April 2016. PMID: 27841978 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - November 16, 2016 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Understanding Cost and Value in Hepatitis C Therapy.
This article summarizes a presentation by Benjamin P. Linas, MD, MPH, at the IAS-USA continuing education program, Management of Hepatitis C Virus in the New Era: Small Molecules Bring Big Changes, held in Atlanta, Georgia, in September 2015. PMID: 27841979 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - November 16, 2016 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

The Affordable Care Act in the United States and HIV Disease: Past, Present, and Future.
This article summarizes a presentation by Timothy M. Westmoreland, JD, at the IAS-USA continuing education program, Improving the Management of HIV Disease, held in Washington, DC, in May 2015. PMID: 27841980 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - November 16, 2016 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Clinically Significant Drug-Drug Interactions Between Hepatitis C Virus and HIV Treatments.
This article summarizes a presentation by Jennifer J. Kiser, PharmD, at the IAS-USA continuing education program, Improving the Management of HIV Disease, held in Los Angeles, California, in April 2016. PMID: 27841981 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - November 16, 2016 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Sexually Transmitted Infections in the Context of HIV Disease: Clinical Implications.
This article summarizes a presentation by Dana W. Dunne, MD, FACP, at the IAS-USA continuing education program, Improving the Management of HIV Disease, held in New York, New York, in March 2016. PMID: 27841982 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - November 16, 2016 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Elements of the HIV Care Continuum: Improving Engagement and Retention in Care.
This article summarizes a presentation by Michael J. Mugavero, MD, MHSc, at the Ryan White HIV/AIDS Program Clinical Care Conference held in New Orleans, Louisiana, in December 2015. PMID: 27841983 [PubMed - in process] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - November 16, 2016 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Treatment of Acute HIV Infection and the Potential Role of Acutely HIV-Infected Persons in Cure Studies.
This article summarizes a presentation by Susan J. Little, MD, at the IAS-USA continuing education program, Improving the Management of HIV Disease, held in Los Angeles, California, in April 2015. PMID: 27398768 [PubMed - as supplied by publisher] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - July 12, 2016 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research

Antiretroviral Therapy for HIV Infection: When to Initiate Therapy, Which Regimen to Use, and How to Monitor Patients on Therapy.
This article summarizes an IAS-USA continuing education webinar presented by Steven C. Johnson, MD, in July 2015. PMID: 27398769 [PubMed - as supplied by publisher] (Source: Topics in antiviral medicine)
Source: Topics in antiviral medicine - July 12, 2016 Category: Infectious Diseases Tags: Top Antivir Med Source Type: research